Pfizer says COVID vaccine protection lasts at least 6 months; Company can now seek full FDA approval
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The companies can now ...
U.S. regulators approved Pfizer’s updated COVID-19 shot Wednesday but with limits that could complicate access for millions of American adults and children.Pfizer said in a release its vaccine is now ...
In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Pfizer Inc. is one of them. Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to advance ...
The Food and Drug Administration on Monday issued full approval to the two-dose Pfizer COVID-19 vaccine. “The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results